For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Bristol-Myers Company

USPTO Granted Patents = 637

CIPO Patents = 2

Trademarks = 19

Forward Citations = 7,812

Loading Chart...

Loading Chart...

409 inventors (with patents filed for the assignee):

Masataka Konishi (48 out of 69 patents)

Ronnie R Crenshaw (46 out of 47 patents)

Takayuki Naito (43 out of 52 patents)

4. Murray A Kaplan (38 out of 49 patents)

5. Terrence W Doyle (34 out of 47 patents)

6. Aldo A Algieri (34 out of 34 patents)

7. Koji Tomita (30 out of 56 patents)

8. Jun Okumura (30 out of 30 patents)

9. Dolatrai M Vyas (28 out of 48 patents)

10. Richard A Partyka (28 out of 38 patents)

11. Takeo Miyaki (26 out of 35 patents)

12. Takushi Kaneko (24 out of 60 patents)

13. Hiroshi Kawaguchi (24 out of 88 patents)

14. Alphonse P Granatek (20 out of 20 patents)

15. Toshikazu Oki (18 out of 61 patents)

Core Competencies:

Aryloxyanilides

Dideoxy Nucleosides

Antitumor Antibiotics

Epipodophyllotoxin Derivatives

Antihypercholesterolemic Compounds

Peptide Antibiotics

Cyclodextrin Complexes

Serine Analogs

Tetrazole Compounds

Antifungal Antibiotics

Psychotropic Derivatives

Cephalosporin Salts

637 patents: Sort by Forward Citations

1. 6090854 - Aryloxyanilides and related compounds (2000-07-18),

2. 5218106 - 2',3'-dideoxy-2'-fluoronucleosides (1993-06-08),

3. 5164379 - Sucralfate/cyclodextrin complexes (1992-11-17),

4. 5130421 - Production of 2',3'-dideoxy-2',3'-didehydronucleosides (1992-07-14),

5. 5126506 - 2',3'-Dideoxy-2'-fluoronucleosides (1992-06-30),

6. 5120862 - Intermediates for the production of epipodophyllotoxin and related (1992-06-09),

7. 5116845 - BU-3420T antitumor antibiotic (1992-05-26),

8. 5114857 - Actinomadura hibisca microorganism useful for preparing serine analogs (1992-05-19),

9. 5110960 - Antifungal antibiotics (1992-05-05),

10. 5110940 - Antihypercholesterolemic tetrazole compounds (1992-05-05),

11. 5106996 - Process for the preparation of podophyllotoxin (1992-04-21),

12. 5099016 - Substituted 7-oxomitosanes (1992-03-24),

13. 5097036 - Substituted 7-oxomitosanes (1992-03-17),

14. 5096817 - Process for producing antibiotics BU-3608 D and BU-3608 E (1992-03-17),

15. 5095011 - Lyophilized cefepime dihydrochloride for parenteral use (1992-03-10),

Bristol-Myers Squibb Company is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines to help patients in need. With a diverse portfolio of drugs and a commitment to research and development, Bristol-Myers Squibb aims to improve patient outcomes and advance healthcare worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

637 Patents

#24 in New York, NY

#46 in New York

#754 in US

#1,510 in the World

New York, NY, United States of America

Bristol-Myers Company

Forward Citations = 7,812

409 inventors:

Masataka Konishi (48 out of 69 patents)

Ronnie R Crenshaw (46 out of 47 patents)

Takayuki Naito (43 out of 52 patents)

4. Murray A Kaplan (38 out of 49 patents)

5. Terrence W Doyle (34 out of 47 patents)

Please report any incorrect information to support@idiyas.com

Loading…